Next Generation Biomaterials/BioMedical Devices:
U.S. & E.U. Market Trends & Commercial Implications
| Hard Copy Print Edition: $1,495 USD |
Published November 2010 by
MRG, Inc. and Fuji-Keizai |
| PDF Single-Departmental License: $2,295 USD |
Pages: 149 |
| PDF Corporate-Wide License: $3,495 USD |
Order |
California orders please add 8.25% sales tax |
Inquries |
Executive Summary
This report reviews, analyzes and sizes the biomaterial/biomedical device markets, particularly focusing on the US and EU region, with five-year revenue projections to 2014 and 10 year projections to 2020. It also presents R&D activity, competition and company strategy for current and new emerging product developers.
Specific product segments examined include:
- Artificial teeth and roots;
- Artificial bone;
- Artificial joints;
- Artificial blood vessels/stents;
- Artificial kidneys;
- Artificial hearts;
- Artificial heart valves;
- Pacemakers;
- Artificial pancreas;
- Artificial livers;
- Artificial tracheas;
- Artificial gullets;
- Artificial bladders;
- Artificial brain cells;
- Artificial bone marrow;
- Artificial corneas;
- Artificial spinal discs;
- Artificial skin.
Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.
More than 100 detailed tables and figures provide key data about revenues and market size, market share and segments. This report includes 33 company profiles that provide the reader a snapshot of the companies' focus or activities. Internet links help readers access companies' own web sites for further review.
Research Target Companies
Abbott Laboratories, Abiomed, Addition Technology, ATS Medical, B. Braun Melsungen AG, Biomet, Biotronik AG, Boston Scientific, B. Dentsply, Edwards Life Sciences, Integra Life Sciences, Johnson & Johnson, Kinetic Concepts, Medtronic, Mesoblast, Nobel Biocare, Ophtec, Organogenesis, ReNeuron, SanBio, Smith & Nephew, Sorin, St. Jude Medical, Straumann, Stryker, SynCardia, Synthes, Tengion, Theregen, ViacCyte, Wright Medical Technology, Zimmer, Zoll Medical Corp.
Research Target Universities
Chiba University: Pacemakers, Columbia University, Georgia Tech, Indian Institute of Technology, Kharagpur, Johns Hopkins University, Karolinska Institute, Newcastle University, Shahid Beheshti University of Medical Sciences, Stanford University, University of California, Los Angeles (UCLA), University of Gothenburg, University of Pittsburgh, University of Michigan, University of Texas at Austin, University of Washington, Wake Forest University
Table of Contents
| |
Executive Summary |
| |
|
| 1 |
Current & Next Generation Biomaterials/BioMedical Device Regulation in the US and EU |
| 1.1 |
Current Regulations |
| 1.1.1 |
Health Care Reform |
| 1.2 |
Future Regulations |
| |
|
| 2 |
Current & Next Generation Biomaterials/BioMedical Devices Overview |
| 2.1 |
Industry Overview |
| 2.2 |
Players Overview |
| 2.3 |
Technology Overview |
| 2.4 |
Market Growth Overview |
| |
|
| 3 |
US and EU Current & Next Generation Biomaterials/BioMedical Device Market |
| 3.1 |
US and EU Current & Next Generation Biomaterials/BioMedical Devices Market Size and Growth 2009-2014 |
| 3.2 |
US and EU Current & Next Generation Biomaterials/BioMedical Devices Market Size and Growth 2015-2020 |
| 3.3 |
US and EU Current & Next Generation Biomaterials/BioMedical Devices Market by Company |
| 3.4 |
US and EU Current Market by Company, 2009 and 2010 (Projected) |
| |
|
| 4 |
US and EU Current & Next Generation Biomaterials/BioMedical Device Markets |
| 4.1 |
Artificial Teeth and Roots/Implants |
| 4.1.1 |
Artificial Teeth and Roots/Implants Market Forecast, 2009-2014 |
| 4.1.2 |
Artificial Teeth and Roots/Implants Maker Share by Company, 2009 and 2010 |
| 4.1.3 |
Artificial Teeth and Roots/Implants New Products (Next Generation Commercial Implication) and New Players |
| 4.1.4 |
Artificial Teeth and Roots/Implants Biomaterials Used |
| 4.1.5 |
Artificial Teeth and Roots/Implants Potential Market Growth |
| 4.1.6 |
Artificial Teeth and Roots/Implants Players Information |
| 4.2 |
Artificial Bone |
| 4.2.1 |
Market Forecast 2009-2014 |
| 4.2.2 |
Maker Share by Company, 2009 and 2010 |
| 4.2.3 |
New Products (Next Generation Commercial Implication) and New Players |
| 4.2.4 |
Biomaterials Used |
| 4.2.5 |
Potential Market Growth |
| 4.2.6 |
Players Information |
4.3
|
Artificial Joint
Same as above
|
| 4.4 |
Artificial Blood Vessels
Same as above |
| 4.5 |
Artificial Kidneys
Same as above |
| 4.6 |
Artificial Heart
Same as above |
| 4.7 |
Artificial Heart Valves
Same as above |
| 4.8 |
Pacemakers
Same as above |
| 4.9 |
Artificial Pancreas
Same as above |
| 4.10 |
Artificial Liver
Same as above |
| 4.11 |
Artificial Trachea
Same as above |
| 4.12 |
Artificial Gullet
Same as above |
| 4.13 |
Artificial Bladders
Same as above |
| 4.14 |
Artificial Brain Cells
Same as above |
| 4.15 |
Artificial Bone Marrow
Same as above |
| 4.16 |
Artificial Corneas
Same as above |
| 4.17 |
Artificial Spinal Discs
Same as above |
| 4.18 |
Artificial Skin
Same as above |
| |
|
| 5 |
Distribution of Current & Next Generation Biomaterials/BioMedical Devices |
| 5.1 |
Industry Structure |
| 5.2 |
Distribution |
| |
|
| 6 |
Biomaterials/Medicine/Medical Applicable Product Company Strategy |
| 6.1 |
Strategic Alliances, Mergers & Acquisitions and Intellectual Property |
| 6.2 |
R&D Activity and Commercial Implications for Next Generation Products |
| 6.3 |
Biomaterials/Medicine/Medical Products Company Profiles |
| 6.3.1-6.3.33 |
(Total 33 Companies)
Common Research Item:
-Location/Contacts
-Public or Private
-# of Employees
-Revenue and Investors
-Developed Products/Products or Biomaterials Under Development
-Customers
-Special Notes/Other Comments/Hot News |
| |
|
| 7 |
University R&D Center for Current & Next Generation Biomaterials/BioMedical Devices |
| 7.1-7.16 |
(Total 16 Universities)
Common Research Item:
-Location/Contacts
-Invention
-Technology, Products or Biomaterials Under Development
-Application Focus
-Target Customers
-R&D Partners
-Special Notes/Other Comments/Hot News |
| |
|
| 8 |
Important Findings and Suggestions/Recommendations for Business Opportunities |
| 8.1 |
Opportunities in the Established US and EU Biomaterials/BioMedical Devices Market, by Segment |
| 8.2 |
Opportunities in the Emerging US and EU Biomaterials/BioMedical Devices Market, by Segment |
| |
|
| 9 |
Appendix |
| 9.1 |
Selected Companies Mentioned in this Report |
Table of Figures
| Figure 3-1: |
Share of Biomaterials/BioMedical Devices Market by Company, 2009 |
| Figure 3-2: |
Share of Biomaterials/BioMedical Devices Market by Company, 2009 and 2010 |
| Figure 4-1 |
Share of Biomaterials/BioMedical Devices Market by Segment, 2009 |
| Figure 4-2: |
Share of Biomaterials/BioMedical Devices Market by Segment, 2014 |
| Figure 4-3: |
Share of Biomaterials/BioMedical Devices Market by Segment, 2020 |
| Figure 8-1: |
Relative Potential Demand, Market Growth and Degree of Competition for Established Biomaterials/BioMedical Devices Markets, 2010 |
| Figure 8-2: |
Relative Potential Demand, Market Growth and Scientific Understanding for Emerging Biomaterials/BioMedical Devices Markets, 2010 |
Table of Tables
| Table 1-1: |
Medical Device Manufacturer Reporting Requirements, 2010 |
| Table 2-1: |
Biomaterials/BioMedical Devices Market Segment Characteristics, 2010 |
| Table 2-2: |
Key Established and Emerging Biomaterials/BioMedical Devices Companies, 2010 |
| Table 2-3: |
Established and Emerging Biomaterials/BioMedical Device Technologies by Market Segment, 2010 |
| Table 2-4: |
Size and Growth for Biomaterials/BioMedical Device Market Segments, 2010 |
| Table 3-1: |
Total US and EU Biomaterials/BioMedical Devices Market Size and Growth, 2009-2014 |
| Table 3-2: |
Total and Individual Biomaterials/BioMedical Devices Market Size and Growth, 2015-2020 |
| Table 3-3: |
US and EU Biomaterials/BioMedical Devices Market by Company, 2009 |
| Table 3-4: |
US and EU Biomaterials/BioMedical Devices Maker Share by Company, 2009 and 2010 |
| Table 4-1: |
Total and Individual Biomaterials/BioMedical Devices Market Size and Forecast, 2009-2014 |
| Table 4-2: |
Total and Individual Biomaterials/BioMedical Devices Market Size and Forecast, 2015-2020 |
| Table 4-3: |
Artificial Teeth and Roots/Implants Maker Share by Company, 2009 and 2010 |
| Table 4-4: |
Artificial Teeth and Roots/Implants Players Information |
| Table 4-5: |
Maker Share by Company, 2009 and 2010 |
| Table 4-6: |
Artificial Bone Players Information |
| Table 6-1: |
Important Recent Alliances, Mergers or Acquisitions |
| Table 6-2: |
Important Settled or Pending Patent Litigation |
| Table 6-3: |
Important Recent or Upcoming Product Launches |
| Table 9-1: |
Major BioMedical Device Companies |
Next Generation Biomaterials/BioMedical Devices: U.S. and E.U. Market Trends & Commercial Implications (November 2010) is 149 pages. A hard copy print edition is available for $1,495.00 USD, a PDF single-departmental license for $2,295.00 USD, and a PDF corporate license for $3,495.00 USD. For more information or to order the report, contact Rob Smith at 1-408-453-5553 or rsmith@mrgco.com.
Order Form
|
